IT7919369A0 - Derivati della tienoidantoina ad azione terapeutica. - Google Patents

Derivati della tienoidantoina ad azione terapeutica.

Info

Publication number
IT7919369A0
IT7919369A0 IT7919369A IT1936979A IT7919369A0 IT 7919369 A0 IT7919369 A0 IT 7919369A0 IT 7919369 A IT7919369 A IT 7919369A IT 1936979 A IT1936979 A IT 1936979A IT 7919369 A0 IT7919369 A0 IT 7919369A0
Authority
IT
Italy
Prior art keywords
thienohydantoin
derivatives
therapeutic action
therapeutic
action
Prior art date
Application number
IT7919369A
Other languages
English (en)
Other versions
IT1110007B (it
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IT7919369A0 publication Critical patent/IT7919369A0/it
Application granted granted Critical
Publication of IT1110007B publication Critical patent/IT1110007B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT19369/79A 1978-01-18 1979-01-17 Derivati della tienoidantoina ad azione terapeutica IT1110007B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/870,542 US4127665A (en) 1978-01-18 1978-01-18 Thienohydantoin derivatives

Publications (2)

Publication Number Publication Date
IT7919369A0 true IT7919369A0 (it) 1979-01-17
IT1110007B IT1110007B (it) 1985-12-23

Family

ID=25355609

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19369/79A IT1110007B (it) 1978-01-18 1979-01-17 Derivati della tienoidantoina ad azione terapeutica

Country Status (11)

Country Link
US (1) US4127665A (it)
JP (1) JPS54109975A (it)
BE (1) BE873500A (it)
DE (1) DE2901477C2 (it)
DK (1) DK151260C (it)
FR (1) FR2415112A1 (it)
GB (1) GB2012759B (it)
IE (1) IE47726B1 (it)
IT (1) IT1110007B (it)
LU (1) LU80795A1 (it)
NL (1) NL176459B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4210667A (en) * 1979-04-19 1980-07-01 Pfizer Inc. Pharmaceutical preparations containing coumarin carboxylic acid derivatives
US4490381A (en) * 1979-11-13 1984-12-25 Imperial Chemical Industries Plc 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones
EP0065393B1 (en) * 1981-05-12 1984-12-27 Imperial Chemical Industries Plc Pyrrole derivatives
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US5070100A (en) * 1983-09-14 1991-12-03 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives
US4864028A (en) * 1983-09-14 1989-09-05 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US5153211A (en) * 1983-09-14 1992-10-06 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US4680306A (en) * 1984-07-20 1987-07-14 Pfizer Inc. Sprio-imidazolones for treatment of diabetes complications
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
JP2708507B2 (ja) * 1988-04-07 1998-02-04 株式会社三和化学研究所 (d)‐6‐フルオロ‐2,3‐ジヒドロ‐2’,5’‐ジオキソ‐スピロ[4H‐1‐ベンゾピラン‐4,4’‐イミダゾリジン]‐2‐カルボキサミド誘導体、これらの製法及び用途
JPH05508386A (ja) * 1989-02-10 1993-11-25 ワシントン リサーチ ファンデション 免疫調整剤
NZ731621A (en) 2009-12-04 2019-01-25 Sunovion Pharmaceuticals Inc Multicyclic compounds and methods of use thereof
KR20190065246A (ko) 2016-07-29 2019-06-11 선오비온 파마슈티컬스 인코포레이티드 화합물 및 조성물 및 이들의 용도
IL264446B1 (en) 2016-07-29 2024-05-01 Pgi Drug Discovery Llc Compounds and compositions and their use
IL268694B2 (en) 2017-02-16 2023-10-01 Sunovion Pharmaceuticals Inc Treatment of schizophrenia
EP3661929B1 (en) 2017-08-02 2021-07-14 Sunovion Pharmaceuticals Inc. Isochroman compounds and uses thereof
WO2019161238A1 (en) 2018-02-16 2019-08-22 Sunovion Pharmaceuticals Inc. Salts, crystal forms, and production methods thereof
AU2020236225A1 (en) 2019-03-14 2021-09-16 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
US11738002B2 (en) 2020-04-14 2023-08-29 Sunovion Pharmaceuticals Inc. Methods of treating neurological and psychiatric disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB796069A (en) * 1955-12-23 1958-06-04 Ici Ltd Substituted hydantoins
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Also Published As

Publication number Publication date
NL176459B (nl) 1984-11-16
BE873500A (fr) 1979-07-16
GB2012759A (en) 1979-08-01
DK151260B (da) 1987-11-16
FR2415112A1 (fr) 1979-08-17
LU80795A1 (fr) 1979-09-07
FR2415112B1 (it) 1983-01-14
JPS54109975A (en) 1979-08-29
JPS612067B2 (it) 1986-01-22
IE790088L (en) 1979-07-18
GB2012759B (en) 1982-05-26
DK19579A (da) 1979-07-19
NL7900354A (nl) 1979-07-20
IT1110007B (it) 1985-12-23
DE2901477A1 (de) 1979-07-19
DE2901477C2 (de) 1982-06-09
IE47726B1 (en) 1984-05-30
DK151260C (da) 1988-05-09
US4127665A (en) 1978-11-28

Similar Documents

Publication Publication Date Title
IT7919369A0 (it) Derivati della tienoidantoina ad azione terapeutica.
IT8025206A0 (it) Derivati di 4-fenil-ftalazine ad azione terapeutica.
IT1092170B (it) Derivati della morfolina
IT7923695A0 (it) Derivati di fenilpiperazina.
IT7927311A0 (it) Derivati spiro-policiclicimidazolidinadionici.
IT7819738A0 (it) Derivati della trimetilchinolina.
IT7919817A0 (it) Derivati della cumarina.
IT7919091A0 (it) Derivati della prostaglandina.
IT7922720A0 (it) Derivati 4-ammino-2-piperidinochinazolinici ad azione terapeutica.
IT7925083A0 (it) Derivati di cloroambucile.
IT8022594A0 (it) Derivati della paromomicina.
IT1193842B (it) Derivati della cisteina
IT7819786A0 (it) Derivati della ossadiazolo-pirimidina.
IT7923871A0 (it) Derivati propossilici ad azione tossica.
IT8125763A0 (it) Derivati della naftiridina.
IT7920543A0 (it) Derivati benzilidenici.
IT7821578A0 (it) Derivati della chinazolina.
NL7903017A (nl) N-alkenylmoranolinederivaten.
IT1114249B (it) Derivato della tetraidro-isochinolina
IT8020503A0 (it) Derivati della 1,1'-bifenil-2-ilalchilammina ad azione farmaceutica.
IT7829762A0 (it) Derivati naftalimidici.
NL7900303A (nl) Fenylpyrroolderivaten.
IT7821364A0 (it) Nuovi derivati del9-fluoroprednisolone.
IT7921115A0 (it) Derivati di ciclitolammine ad azione farmaceutica.
IT7824869A0 (it) Derivati della naftiridina.